Lava Medtech Acquisition Stock Z Score
LVACUDelisted Stock | USD 10.40 0.00 0.00% |
Lava |
Lava Medtech Acquisition Company Z Score Analysis
Lava Medtech's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Lava Medtech Z Score | -0.24 |
Most of Lava Medtech's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lava Medtech Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Lava Medtech Acquisition has a Z Score of -0.24. This is 109.96% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The z score for all United States stocks is 102.75% higher than that of the company.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
All Next | Launch Module |
Lava Fundamentals
Return On Asset | -0.0081 | |||
Shares Owned By Institutions | 10.18 % | |||
Number Of Shares Shorted | 105 | |||
EBITDA | (6.22 M) | |||
Net Income | 4.5 M | |||
Cash And Equivalents | 1.15 M | |||
Cash Per Share | 0.08 X | |||
Total Debt | 92.81 K | |||
Debt To Equity | 4.92 % | |||
Current Ratio | 18.29 X | |||
Book Value Per Share | (0.21) X | |||
Cash Flow From Operations | (658.82 K) | |||
Short Ratio | 1.88 X | |||
Total Asset | 120.67 M | |||
Retained Earnings | (3.01 M) | |||
Working Capital | (3.39 M) | |||
Z Score | -0.24 | |||
Net Asset | 120.67 M |
About Lava Medtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lava Medtech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lava Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lava Medtech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Lava Stock
If you are still planning to invest in Lava Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lava Medtech's history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |